We welcome all the dynamic scholars from all over globe to attend the Webinar on Pharmacology scheduled on December 04, 2024. This pharmacology webinar will be organized around the theme Immunopharmacology: Targeting the Immune System in Disease. This is the best opportunity for those who have centered their focus on the pharmacology and want to share with the rest of the world. Presentations, distribution of information, meetings with current and potential scientists, discussions on the new developments and research and receiving recognition at this event are the main motives of this webinar.
Renowned speakers all over the globe are welcomed to talk about their researches, developments and also discuss the latest updates and new techniques in pharmacology are hallmarks of this Pharmacology webinar.
The 2024 pharmacology market is being shaped by several key trends. Generative AI is transforming drug development and clinical trials by enhancing drug discovery and improving patient recruitment. The rise of decentralized and hybrid clinical trials is expanding access and reducing barriers for diverse patient populations. Additionally, innovation in therapeutic modalities like mRNA, CRISPR, and antibody-drug conjugates is driving significant growth, particularly in oncology. The industry is also adapting to demographic shifts, with a focus on preventive care and managing the burden of chronic diseases
The pharmaceutical market is undergoing a profound transformation, shaped by external forces and internal dynamics. These pharma industry trends include downward price pressure on pharma patent values from the Inflation Reduction Act, declining M&A deal values, and rising life sciences salaries. The upside potential for new therapies has decreased, with payers becoming more selective and pressuring manufacturers. Physicians are becoming less inclined to entertain meetings with multiple biopharma companies. And organizations are facing data overwhelm and data governance challenges, making it difficult to translate the potential in their data into reality.
Market Analysis of Global Pharmaceutical Industries
The global $1.12 trillion market in 2023, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2023. Generics sales will increase from $73 billion in 2015 to $115 billion in 2023, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.
The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.
